The New Criterion

Another biotech shooting star falls to earth after a poor clinical trial. Meanwhile, PNG-focused Mayur Resources’ $15.5 million IPO looks likely to close oversubscribed on the back of its multi-commodity strategy. ResApp (RAP) 8.3c The best-performing ASX stock of 2015,…

The New Criterion

If new IPO CropLogic has its way, it’s not just Eric Olthwaite who will be getting excited about rain gauges and precipitation. Meanwhile, the globalized Fluence is taking on the world’s polluted waterways one filthy drop at a time. Tim…

The New Criterion

Northern Cobalt’s upcoming IPO will test just how much investors still crave the battery metal. In the meantime, oil and gas explorer Whitebark is determined to prove there’s still a buck to be made out of dirty hydrocarbons. Northern Cobalt…

The New Criterion

Just as the traffic camera operator looked to be “moving forward” – obeying all speed limits and red lights of course – along comes another snafu for the strife-prone company. This time Redflex (ASX: RDF) is in the poo in…